(Q35187056)

7 August 2017

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography (English)

1 reference

Mucin 16, cell surface associated

7 August 2017

1 reference

1 reference

Jacobs I

1

1 reference

7 August 2017

Davies AP

2

1 reference

7 August 2017

Bridges J

3

1 reference

7 August 2017

Stabile I

4

1 reference

7 August 2017

Fay T

5

1 reference

7 August 2017

Lower A

6

1 reference

7 August 2017

Grudzinskas JG

7

1 reference

7 August 2017

Oram D

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 April 1993

1 reference

7 August 2017

1 reference

7 August 2017

306

1 reference

7 August 2017

1030-1034

1 reference

7 August 2017

6884

1 reference

Reactivity of a monoclonal antibody with human ovarian carcinoma

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Multimodal approach to screening for ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

The CA 125 tumour-associated antigen: a review of the literature

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Transabdominal ultrasound screening for early ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Ovarian cancer.Incidence and case-control study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677033

Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer

13 July 2018

1 reference

12 December 2020

Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3

1 reference

12 December 2020

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer

1 reference

12 December 2020

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

1 reference

12 December 2020

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1 reference

12 December 2020

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

12 December 2020

Real-time ultrasonography for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer?

1 reference

12 December 2020

Circulating tumor markers in the monitoring of gynecologic malignancies

1 reference

12 December 2020

Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened

1 reference

12 December 2020

Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass

1 reference

12 December 2020

10.1136/BMJ.306.6884.1030

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference